Associated technologies
Lipocube Nano is described by its manufacturer as a single-use mechanical device for processing autologous lipoaspirate into microfat and nanofat.[1] In practical terms, it belongs to the tissue-processing stage: fat is aspirated as part of a planned procedure and may then be processed according to the technical objective discussed during evaluation. The device itself does not determine whether grafting is indicated, where tissue should be placed, or what result a particular patient will obtain.
The relevant clinical question is therefore not simply whether Lipocube is available. It is whether processing lipoaspirate is appropriate for the patient’s anatomy, goals, tissue characteristics, overall health, examinations, surgical plan, and care setting. These factors are discussed in consultation and remain more important than making a device the center of the decision.[2]
Complementary resources
Nanofat and microfat are terms for processed adipose tissue, not predefined a particular therapeutic effect. A review describes nanofat as an area of research and application in plastic surgery, but the available material does not support promises of regeneration, persistence, projection, or a specific benefit in gluteal reshaping.[3] The purpose of processing, the intended use, and the technical steps must be explained in relation to the individual plan.
In procedures involving fat transfer, the fact that tissue is autologous does not eliminate risks. Particularly in gluteal fat grafting, professional safety guidance emphasizes patient selection, training, the care environment, technique, and specific safety measures.[4] Lipocube can be discussed as one mechanical processing resource within that broader framework.
Key considerations
The consultation should clarify the complaint, anatomy, expectations, possible alternatives, and limits of treatment. The assessment may consider the distribution of fat, skin quality and elasticity, changes in weight, clinical conditions, examinations, the planned procedure, anesthesia, team, and appropriate hospital structure. Skin quality influences contour response, and excess skin may require another strategy rather than tissue processing alone.[2]
If a plan includes processing lipoaspirate, the team should explain its intended role, the relevant steps, possible limitations, and follow-up. The indication and local regulatory requirements must be reviewed before publication or clinical use. No device can replace examination, informed consent, or individualized medical judgment.
Clinical context
| Technical element | Confirmed description | What remains individual |
|---|---|---|
| Device | Lipocube Nano is described as a single-use mechanical device. | Whether it is indicated for a specific patient or procedure. |
| Input material | Autologous lipoaspirate obtained within a planned procedure. | The amount, quality, and suitability of the aspirated tissue. |
| Processing | Processing into microfat and nanofat is described. | The technical objective and handling protocol. |
| Clinical role | A tissue-processing resource within a broader surgical plan. | Placement, combination with other steps, follow-up, and expected course. |
| Regulatory context | Manufacturer documentation does not establish an individual clinical result or replace local evaluation. | Applicable authorization, availability, and medical review. |
Technology and care
Lipocube does not define regeneration, duration, projection, volume, contour, symmetry, or any other outcome in advance. It does not eliminate the risks of fat grafting, make an indication automatic, replace clinical examination or complementary tests, or determine the surgical plan by itself. It also does not make an autologous procedure risk-free. Results and recovery cannot be predicted from the device name alone, and no technology dispenses with informed discussion of alternatives, limitations, complications, and follow-up.
Frequently asked questions
Is Lipocube a treatment by itself?
No. It is described as a mechanical, single-use device for processing lipoaspirate. Its role, if any, is part of an individualized procedure and plan.
can tissue regeneration?
No. The available evidence does not justify promising regeneration, duration, projection, or a specific benefit. Nanofat remains a field with research and clinical applications that require careful indication.[3]
Does autologous fat eliminate risk?
No. Autologous origin does not remove the risks of processing or grafting. Gluteal fat grafting requires specific selection, training, technique, environment, and safety measures.[4]
Can Lipocube define the final result?
No. The result depends on the patient, anatomy, tissue, procedure, technical plan, healing, and follow-up. A device cannot define an individual outcome.
Is Lipocube indicated for everyone seeking fat transfer?
No. Suitability must be assessed in consultation, with consideration of clinical conditions, examinations, objectives, alternatives, and applicable regulation. Availability and indication may vary by patient and jurisdiction.
References
> Medical review note: Institutional information provided by Dr. Antônio Teixeira. Medical review is required before publication.